During the past decade, Leeds Institute of Cardiovascular and Metabolic Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leeds Institute of Cardiovascular and Metabolic Medicine" #1 collaborator was "National Institute for Health Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Leeds Institute of Cardiovascular and Metabolic Medicine" are "Chronic Heart Failure" (2 trials), "Arrhythmia, Sinus" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Leeds Institute of Cardiovascular and Metabolic Medicine" in a lesser frequency.

Most popular intervention types in "Leeds Institute of Cardiovascular and Metabolic Medicine" are "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atrial fibrillation" (1 trials), "Ivabradine" (1 trials), "Placebo" (1 trials) and "Tailored pacemaker settings" (1 trials). Other intervention names were less common.

The vast majority of trials in "Leeds Institute of Cardiovascular and Metabolic Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Leeds Institute of Cardiovascular and Metabolic Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Leeds Institute of Cardiovascular and Metabolic Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Leeds Institute of Cardiovascular and Metabolic Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".